XH2224

ICD-11 MMS 2026-01

Undifferentiated carcinoma with osteoclast-like giant cells

Index terms

  • Undifferentiated carcinoma with osteoclast-like giant cells

Sibling codes

  • XH00N7 – Glassy cell carcinoma
  • XH0793 – Combined small cell-adenocarcinoma
  • XH0NL5 – Large cell neuroendocrine carcinoma
  • XH0YB0 – Small cell carcinoma, NOS
  • XH1DU4 – Non-small cell carcinoma
  • XH1JZ2 – Giant cell carcinoma
  • XH1YN3 – Carcinoma, metastatic, NOS
  • XH1YY4 – Carcinoma, undifferentiated, NOS
  • XH26N1 – Heterotopia-associated carcinoma
  • XH2855 – Nuclear protein in testis (NUT) associated carcinoma
  • XH28J9 – Oat cell carcinoma
  • XH2BS4 – Squamous carcinoma with osteoclast-like giant cells
  • XH35G0 – Pleomorphic carcinoma
  • XH35M3 – Pseudosarcomatous carcinoma
  • XH3RZ4 – Spindle cell carcinoma, NOS
  • XH3T00 – Small cell carcinoma, fusiform cell
  • XH3XZ6 – Giant cell and spindle cell carcinoma
  • XH45J4 – Large cell carcinoma, NOS
  • XH4P61 – Epithelioma, malignant
  • XH4QU2 – Large cell carcinoma with rhabdoid phenotype
  • XH56X7 – Carcinoma with osteoclast-like giant cells
  • XH57U9 – Carcinoma, anaplastic, NOS
  • XH5R16 – Dedifferentiated carcinoma
  • XH63D2 – Carcinoma, NOS
  • XH6FK9 – Combined small cell-large cell carcinoma
  • XH6GK0 – Small cell carcinoma, intermediate cell
  • XH7YE3 – Combined small cell carcinoma
  • XH8D74 – Carcinomatosis
  • XH8ZR8 – Small cell carcinoma, hypercalcaemic type
  • XH90B3 – Combined large cell neuroendocrine carcinoma
  • XH92T7 – Polygonal cell carcinoma
  • XH98Z7 – Anaplastic undifferentiated carcinoma
  • XH9SY0 – Small cell neuroendocrine carcinoma
  • XH9ZD2 – Combined small cell-squamous cell carcinoma

Foundation entity

Undifferentiated carcinoma with osteoclast-like giant cells – http://id.who.int/icd/entity/646690224

Part of: X: Extension Codes